These tech stocks are a buy ahead of their earnings reports, Bank of America says

Bank of America highlighted several buy-rated technology stocks ahead of quarterly results, citing AI exposure and growth prospects. It raised its Box price target 19% to $50 from $42; Box shares are up 32% this year. For Coupang, the bank estimates 3Q revenue of $10.18 billion, slightly above consensus, but adjusted EBITDA of $151 million, below the $157 million consensus; Spotify is down almost 9% this year despite the bank’s bullish view.

Analysis

The key distinction is earnings visibility, not the shared AI label. APH sells into broad infrastructure demand across accelerator architectures, which may make its thesis less dependent on any single chip winner; the risk is that customer capex pauses would hit several suppliers together. CAMT is a more concentrated advanced-packaging growth exposure, and its thesis leans on share gains plus a long-dated market forecast: verify orders and customer adoption rather than treating projected demand as near-term earnings. BOX has the clearest valuation-re-rating narrative, but its sharp recent appreciation raises the bar for evidence that AI features improve paid adoption, retention, or pricing—not merely product engagement. SPOT's scale may help defend discovery and engagement, yet AI alone does not establish better economics; advertising yield, pricing, and content costs matter. CPNG's currency-supported revenue estimate alongside softer EBITDA is a quality-of-growth warning, not a clean operating beat.

Near term, analyst endorsements can support sentiment into results, but disappointments may be amplified after recent appreciation in BOX and the AI-linked names. Over 1–3 months, focus on guidance, order trends, and measurable monetization; over 6–18 months, the main upside is sustained AI infrastructure buildout and enterprise AI usage. The contrarian risk is treating these as one basket: infrastructure spending can persist while software monetization or consumer-platform economics disappoint. This is analyst commentary, not independent confirmation. Verify report dates, estimate revisions, valuation, and company disclosures before sizing.

Key Decisions for Investors

• Prefer APH over a broad, undifferentiated AI basket for infrastructure exposure, but add only if results or guidance confirm demand across end markets; cut the thesis on evidence of order deceleration or customer capex deferrals.
• Treat CAMT as a higher-beta, concentrated expression of advanced packaging. Keep exposure smaller than APH and require confirmation of orders/share gains; reassess if management commentary weakens on packaging demand or customer diversification.
• Do not chase BOX solely on the AI narrative after its substantial run. Watch reported customer growth, retention, and evidence of AI-related upsell; absent those, a positive earnings reaction may be vulnerable to reversal.
• For SPOT, consider staged exposure around results rather than an unconditional pre-event position. The thesis strengthens with improving ad monetization and subscriber/pricing trends; it is falsified by weaker engagement or deteriorating content economics.
• Keep CPNG on watch rather than buying a revenue beat at face value: separate FX translation from underlying growth and monitor EBITDA conversion. A persistent gap between revenue and profit performance would weaken the case.